NET PROFIT (x1000 EUR)
EMPLOYEES
Wilson Therapeutics AB
Closing information (x1000 EUR)
Closing information | 2020/12 | 2019/12 | 2018/12 |
Turnover | 0 | 0 | 0 |
Financial expenses | 87,768 | 217 | 328 |
Earnings before taxes | -67,516 | 645,902 | -38,065 |
EBITDA | -83 | 638,155 | -39,132 |
Total assets | 641,755 | 1,247,207 | 7,857 |
Current assets | 641,745 | 1,247,067 | 1,392 |
Current liabilities | 6,681 | 571,290 | 4,346 |
Equity capital | 635,074 | 675,918 | 3,498 |
- share capital | 313 | 301 | 306 |
Employees (average) | 0 | 1 | 14 |
Financial ratios
Fiscal year | 2020/12 | 2019/12 | 2018/12 |
Solvency | 99.0% | 54.2% | 44.5% |
Turnover per employee | 0 | 0 | |
Profit as a percentage of turnover | |||
Return on assets (ROA) | 3.2% | 51.8% | -480.3% |
Current ratio | 9605.5% | 218.3% | 32.0% |
Return on equity (ROE) | -10.6% | 95.6% | -1088.2% |
Change turnover | 0 | 0 | 0 |
Change turnover % | |||
Chg. No. of employees | -1 | -13 | 0 |
Chg. No. of employees % | -100% | -93% |
Total value of public sale
Fiscal year | 2020/12 | 2019/12 | 2018/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.